Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Chimeric Therapies initiates pivotal trial evaluating proprietary method for allogeneic BMT

June 25, 1999

Avant achieves milestone in rotavirus vaccine program with SB

June 25, 1999

AM-6898E: new anti-IgE antibody agent for immune disorders

June 24, 1999

PowderJect and Glaxo Wellcome further expand DNA vaccine alliance

June 24, 1999

Vaccines and vaccine vectors comprising auxotrophic attenuated strains of Listeria

June 18, 1999

Potassium channel-modulating immunosuppressants designed at Merck

June 18, 1999

NIAID sponsors phase III trial of varicella vaccine for prevention of shingles

June 18, 1999

Campylobacter vaccine completes phase II trial

June 17, 1999

Stable immunomodulators related to Imreg-1 developed at BioChem Pharma

June 17, 1999

U.S. patent granted for conjugate vaccine against group B streptococci

June 17, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Hits’ Hyperlab launches as ‘virtual AI lab’ for new drug discovery
BioWorld Science
Things once done in laboratories can now be done with computers and AI, said Kim Woo-youn, CEO and cofounder of Hits Inc. “We live in the age of ‘digital...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...